---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-027331"
form_type: "8-K"
ticker: "IDXG"
cik: "0001054102"
company_name: "INTERPACE BIOSCIENCES, INC."
filed_at: "2023-08-09T23:59:59+00:00"
generated_at: "2026-06-11T21:12:04.878851+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Interpace Q2 revenue $11.0M (+49% YoY); net income $0.4M vs loss

## Summary
- Q2 net revenue $11.0M, up 49% YoY; gross margin improved to 62% from 52%.
- Income from continuing operations $0.4M vs loss of $2.1M in Q2 2022.
- Adjusted EBITDA $1.3M vs $(1.6)M loss; cash collections $10.2M, up 23% YoY.
- Test volume up 15% YoY; cash balance increased to $5.1M from $1.9M.
- Company faces Novitas LCD challenge for PancraGEN test; expects resolution in months to year.

## SEC filing metadata
- accession: 0001493152-23-027331
- form_type: 8-K
- ticker: IDXG
- cik: 0001054102
- company_name: INTERPACE BIOSCIENCES, INC.
- filed_at: 2023-08-09T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1054102/000149315223027331/0001493152-23-027331-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1054102/000149315223027331/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-027331
- JSON: https://secwatch.observer/filing/0001493152-23-027331.json
- Plain text: https://secwatch.observer/filing/0001493152-23-027331.txt

## Key facts
- Earnings Releases
  INTERPACE BIOSCIENCES, INC. reported second quarter ended June 30, 2023 results: revenue Net Revenue was $11.0 million, net income Income from continuing operations was $0.4 million.
  - Period: second quarter ended June 30, 2023
  - Revenue: Net Revenue was $11.0 million
  - Net income: Income from continuing operations was $0.4 million
  - Result: reported results
  source text: Second quarter Net Revenue was $11.0 million, a $3.6 million increase over second quarter 2022. Income from continuing operations in the second quarter of 2023 was $0.4 million, an improvement of $2.5 million from the prior year quarter's loss of $2.1 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1054102/000149315223027331/0001493152-23-027331-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.